Placebos and Neurofeedback: A Case for Facilitating and Maximizing Placebo Response in Neurofeedback Treatments
AbstractThis article provides an overview of the nature of placebo responses. A critical review is provided of placebo-controlled psychopharmacology research, demonstrating that a large proportion of the improvements resulting from psychiatric medication treatments is the result of placebo effects. This finding calls into question the degree to which psychiatric treatments are genuinely evidence based. The value, limitations, and ethical problems associated with placebo-controlled research in the field of neurofeedback are then discussed. Placebo effects are an active ingredient in all therapeutic modalities. Rather than being a negative to be controlled, however, clinicians can view placebo responses as actually representing a resource to be encouraged and maximized. Practical examples are offered for creating positive expectancies and for the use of positive suggestions to further enhance neurofeedback treatment outcomes.
© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article. From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).